Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Research & Development In Brief

This article was originally published in The Tan Sheet

Executive Summary

Cancer survivors' CAM use: Slightly more than 40 percent of adult cancer survivors use nutritional supplements and vitamins as a complement to conventional treatment, according to a study of complementary treatment methods published online Aug. 4 in the journal Cancer. Affluent, well-educated Hispanics and "other" racial groups are more likely to take vitamins and supplements, as are women and breast and ovarian cancer survivors, according to the longitudinal, nationwide study for the American Cancer Society which surveyed 5,901 adult cancer survivors. The complementary method most frequently reported of the 19 included in the survey was prayer/spiritual practice (61.4 percent), while relaxation as treatment was reported by 44.3 percent and faith/spiritual healing by 42.4 percent, say the researchers led by Ted Gansler, a physician and member of the ACS staff

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS102033

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel